science reporter covering biomedical research at Nature | proudly Ukrainian 🇺🇦
maxkozlov.com
signal: mkozlov.01
Max Kozlov
Loading...
Nature has learnt that a clinical trial of two therapies against the rare Ebola Bundibugyo virus spreading in Africa is in the works, pending approval by the governments of DRC and Uganda.
go.nature.com/4uNZU0i
NIAID employees did not receive any communication about these leadership changes until this afternoon, when the institute sent out an unsigned email.
NIAID employees did not receive any communication about these leadership changes until this afternoon, when the institute sent out an unsigned email.
When you survive a global pandemic, you are never quite the same. I wrote a reflection on the Hantavirus outbreak aboard the Hondius, the invisible work of outbreak containment, and how COVID changed the way many of us process fear, trust, and infectious threats.
open.substack.com/pub/bktitanj...
Clinical trials for treatments against Ebola Bundibugyo virus are ‘in a strong position’ to be launched quickly in the Democratic Republic of the Congo and Uganda.
This forced reassignment of career scientists is highly unusual for the NIH. Career scientists are typically not replaced when presidential administrations change. Some scientists fear this shows a growing political influence over science at the institute.
Most recently, three senior officials—Daniel Rotrosen, Kelly Poe, and Andrea Wurster—were given the choice to either accept reassignment outside the institute or resign. Notably, all three of these scientists worked under former director Anthony Fauci.
This mirrors a broader trend, as 16 of the NIH's 27 institutes and centres currently lack permanent directors. These removals also come as the administration pursues charges against some scientists involved with COVID-19 research who were in Fauci's orbit.
